News | August 02, 2022
Thyrocare Technologies posts Q1FY23 consolidated PAT at Rs. 21.73 Cr
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice
Q2 FY25 Total Income was at Rs. 85.4 crore
Time to combine innovation, access and technology to deliver positive patient outcomes
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
A staggering 65% of the TB cases in India are in the 15-45 age group
Subscribe To Our Newsletter & Stay Updated
